ADCs / bioconjugates pose a complex challenge from a development and manufacturing perspective. We offer a complete end to end solution that simplifies the value chain and accelerates the timeline to the clinic or the market.
Our full-service offering for bioconjugates/ADCs provides you with:
- Early de-risking and optimization
- Process development and optimization
- Formulation development
- Analytical development
- Targeting agent or carrier protein
- Drug substance manufacture
- Drug product manufacture
- Payload and linker manufacturing
We have a successful track record of marketed bioconjugates, providing support through all stages of the lifecycle from concept to commercialization.
Our experience spans a broad range of technologies including:
- ADC’s
- AOC’s (Antibody Oligonucleotide Conjugates)
- Antibodies conjugated to nanoparticles (TNPs) and non-cytotoxic drugs (including peptides and polymers
- Conjugated duobodies
- Radio-immunoconjugates (mAb conjugated to chelating agents)
- Vaccines (haptens conjugated to carrier proteins)
- PEGylation and cross-linking
Our locations
Virtual Tour: Bioconjugates Large Scale Manufacturing (Visp)
The extensive biologics contract development and manufacturing services portfolio in Visp covers advanced technologies to quickly and efficiently deliver products. For Bioconjugates, comprehensive CDMO Services in the technology areas of Small Molecules, Mammalian, Microbial, Bioconjugation, and Drug Product are available to provide an end-to-end supply solution with reduced complexity.
Our offering includes preclinical, drug substance, and drug product development. This Virtual tour presents bioconjugates large-scale manufacturing room examples in Visp, Switzerland. For more information and/or tours, please reach out to us or visit our Visp location page.